Age upon enrollment (years) |
|
10.7 (2.97) |
5–17 |
Age at diagnosis (years) |
|
5.6 (4.07) |
1–17 |
Biological sex (females) |
8 (44%) |
|
|
Treatment status |
Treatment status |
Treatment status |
Treatment
status |
Current treatment (patient) |
5 (27.8%) |
|
|
Past treatment (survivor) |
13 (72.2%) |
|
|
Cancer diagnosis |
Cancer diagnosis |
Cancer diagnosis |
Cancer
diagnosis |
Acute lymphoblastic leukemia (ALL) |
12 (66.4%) |
|
|
Acute promyelocytic leukemia (APML) |
1 (5.6%) |
|
|
B-cell lymphoma |
1 (5.6%) |
|
|
Neuroblastoma |
1 (5.6%) |
|
|
Wilms Tumor |
1 (5.6%) |
|
|
Ewing’s sarcoma |
1 (5.6%) |
|
|
Juvenile myelomonocytic leukemia (JMML) |
1 (5.6%) |
|
|
Race/ethnicity |
|
|
|
White, Non-Hispanic |
10 (55.5%) |
|
|
White, Hispanic |
1 (5.6%) |
|
|
Black American, Non-Hispanic |
4 (22.2%) |
|
|
Other |
2 (11.1%) |
|
|
Not reported |
1 (5.6%) |
|
|
Annual household income |
|
|
|
$0-10,000 |
1 (5.6%) |
|
|
$10,000-20,000 |
1 (5.6%) |
|
|
$20,000-30,000 |
2 (11.1%) |
|
|
$30,000-40,000 |
3 (16.6%) |
|
|
$40,000-50,000 |
3 (16.6%) |
|
|
$50,000-60,000 |
0 (0%) |
|
|
$60,000-80,000 |
3 (16.6%) |
|
|
$80,000-100,000 |
1 (5.6%) |
|
|
$100,000-120,000 |
2 (11.1%) |
|
|
$120,000-140,000 |
1 (5.6%) |
|
|
Not reported |
1 (5.6%) |
|
|
Baseline posttraumatic stress symptoms (PTSS) |
|
17.37
(14.56) |
3-64 |
Re-experiencing PTSS |
|
4.22 (4.89) |
0-19 |
Avoidance PTSS |
|
2.11 (2.52) |
0-7 |
Negative affect PTSS |
|
4.11 (5.13) |
0-22 |
Hyperarousal PTSS |
|
5 (4.22) |
0-16 |